The Medicines for Malaria Venture (MMV) was established in 1999 as an independent Swiss foundation to finance the research and development of new malaria drugs that are affordable in malaria endemic countries. It is a product development public-private partnership (PD-PPP). This Global Program Review (GPR) assesses the quality and independence of the 2005 evaluation of MMV; provides a second opinion on the effectiveness of MMV's work; assesses the...
See More
DOWNLOADS
COMPLETE REPORT
Official version of document (may contain signatures, etc)
-
Total Downloads** : 287
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.
Citation
The medicines for malaria venture (English). Global program review ; volume 1, no. 2 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/242741468163162367